RETA Quote, Trading Chart, Reata Pharmaceuticals Inc.
home / stock / reta / reta quote
$110.17 Last:
0.15% Change Percent:
$111 Open:
$110.17 Previous Close:
$111 High:
$106.83 Low:
152,252 Volume:
01/21/2021 03:26:10 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-01-21 | 111 | 110.17 | 111 | 106.83 | 152,252 |
| 2021-01-20 | 114.12 | 110 | 115.82 | 109.7 | 299,697 |
| 2021-01-19 | 114.85 | 113.84 | 117.75 | 112.22 | 311,743 |
| 2021-01-18 | 120.98 | 111.93 | 121.715 | 111.8 | 399,079 |
| 2021-01-15 | 120.98 | 111.93 | 121.715 | 111.8 | 398,827 |
| 2021-01-14 | 120.88 | 120 | 122.89 | 119.46 | 204,018 |
| 2021-01-13 | 126.59 | 121.27 | 127.9 | 120.78 | 159,608 |
| 2021-01-12 | 127.94 | 125.96 | 130.43 | 124.52 | 177,635 |
| 2021-01-11 | 120.42 | 126.51 | 129.87 | 119.95 | 352,639 |
| 2021-01-08 | 126.22 | 120.51 | 129.42 | 118.34 | 409,719 |
| 2021-01-07 | 114.15 | 125 | 126.12 | 114.06 | 312,562 |
| 2021-01-06 | 117.52 | 113.1 | 118.43 | 112.01 | 359,275 |
| 2021-01-05 | 121.55 | 118.6 | 121.98 | 116.95 | 236,065 |
| 2021-01-04 | 122.56 | 121.29 | 124.03 | 119.65 | 153,497 |
| 2021-01-01 | 124.82 | 123.62 | 125.45 | 121.5525 | 178,968 |
| 2020-12-31 | 124.82 | 123.62 | 125.45 | 121.5525 | 178,941 |
| 2020-12-30 | 130.14 | 125.01 | 131.22 | 124.365 | 250,603 |
| 2020-12-29 | 129.07 | 129.73 | 130.465 | 124.64 | 258,208 |
| 2020-12-28 | 134.11 | 129.3 | 135.58 | 128.2009 | 319,677 |
| 2020-12-25 | 127.32 | 132.55 | 133.2 | 126.8048 | 212,811 |
Reata Pharmaceuticals Inc. Company Name:
RETA Stock Symbol:
NASDAQ Market:
Reata Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
PLANO, Texas, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 2,000,00...
-
PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it has priced a public offering of 2,000,000 shares by the Company of its Class...
-
PLANO, Texas, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (“FDA”...